Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Bioorg Med Chem Lett. 2012 Apr 13;22(11):3739–3742. doi: 10.1016/j.bmcl.2012.04.023

Table 1.

Tertiary amine TIQ Rev-erbα agonists

graphic file with name nihms412702u1.jpg
Compound R a Max Inh EC50 (μM)
1 0.82 2.3
3a graphic file with name nihms412702t1.jpg 0.78 b NT
3b graphic file with name nihms412702t2.jpg 1.0 NT
3c graphic file with name nihms412702t3.jpg 0.90 NT
3d graphic file with name nihms412702t4.jpg 1.0 NT
3e graphic file with name nihms412702t5.jpg 1.0 NT
3f graphic file with name nihms412702t6.jpg 0.95 NT
a

results are average of 2 or more experiments. Value = fold change relative to DMSO control at 10 μM compound. The lower the number, the more efficacious the agonist in terms of repressing transcription;

b

NT = not tested.

HHS Vulnerability Disclosure